Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in hospitalized diabetic patients with COVID-19
IRCT20230523058271N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in coronavirus disease 2019 (COVID-19) and type 2 diabetes mellitus (T2DM), sponsored by Shahid Sadoughi University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
pentoxifylline
03
Conditions
coronavirus disease 2019 (COVID-19)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20230523058271N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230523058271N1.